J0177 HCPCS Level II Code: Injection, aflibercept hd, 1 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $298.68

61755-0050-01 — Eylea HD — Regeneron Pharmaceuticals, Inc. (size 0.07 × qty 1 (1 MG per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J0177 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (36)

• J0120 — Injection, tetracycline, up to 250 mg[Sibling]
• J0121 — Injection, omadacycline, 1 mg[Sibling]
• J0122 — Injection, eravacycline, 1 mg[Sibling]
• J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)[Sibling]
• J0130 — Injection abciximab, 10 mg[Sibling]
• J0131 — Injection, acetaminophen, not otherwise specified,10 mg[Sibling]
• J0132 — Injection, acetylcysteine, 100 mg[Sibling]
• J0133 — Injection, acyclovir, 5 mg[Sibling]
• and 28 more

Change history

• April 1, 2024 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J0177 in its code family, with their registry titles.

• J0171 — Injection, adrenalin, epinephrine, 0.1 mg
• J0172 — Injection, aducanumab-avwa, 2 mg
• J0173 — Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg
• J0174 — Lecanemab-irmb, for intravenous injection, 1 mg
• J0175 — Injection, donanemab-azbt, 2 mg
• J0178 — Injection, aflibercept, 1 mg
• J0179 — Injection, brolucizumab-dbll, 1 mg
• J0180 — Injection, agalsidase beta, 1 mg
• J0184 — Injection, amisulpride, 1 mg
• J0185 — Injection, aprepitant, 1 mg